Serum Tg Levels in Children and Adolescents with DTC
Time of Tg evaluation* | Hormonal status | Detectable Tg† (>1 ng/mL) | Median (range in ng/mL) | P | ||
---|---|---|---|---|---|---|
Before adjuvant 131I therapy | Off T4 therapy (n = 107) | 72 (67) | 3.5 (0.2–320) | }0.01 | ||
At diagnosis of LR | Off T4 therapy (n = 17) | 17 (100) | 26.3 (1.1–581) | |||
On T4 therapy (n = 6) | 2 (33) | 0.6 (0.2–43) | ||||
At last follow-up (on T4 therapy) | Children with recurrence during follow-up | On T4 therapy (n = 30) | 1 (3) | 0.4 (0.2–1.7) | }NS | |
Children without recurrence during follow-up | On T4 therapy (n = 130) | 5 (4) | 0.3 (0.2–6.5) |